⌘K
Loading ticker…
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · Healthcare · Pharmaceutical Products
As of 2026-06-26, Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) has a 3-month relative strength percentile of 24 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 48. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 1.4%, relative volume 0.93×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
24 is not yet a leadership-grade RS read, Market Stance is 47
Daily range, ATR, beta, and the math for a 1-ADR stop.
TAK is in a stage 3 topping pattern, week 2. Currently in a 86-day base; basing ADR 1.3% (broad 1.2%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: -1.9% / -0.7%.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
TAK appears in 1 ETF as of Mar 2026: FVD at 0.43% weight, $35M notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| FVDFirst Trust Value Line Dividend Index Fund | 0.43% | $35M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TAK Jan avg: 3.81% median: 1.80% win: 100% σ: 4.50% n: 4 2022-04-12 → 2026-05-29 | TAK Feb avg: 3.38% median: 3.77% win: 50% σ: 5.72% n: 4 2022-04-12 → 2026-05-29 | TAK Mar avg: 1.13% median: 0.98% win: 50% σ: 5.29% n: 4 2022-04-12 → 2026-05-29 | TAK Apr avg: -2.82% median: -1.82% win: 40% σ: 5.12% n: 5 2022-04-12 → 2026-05-29 | TAK May avg: -1.87% median: -1.70% win: 20% σ: 2.71% n: 5 2022-04-12 → 2026-05-29 | TAK Jun avg: -0.90% median: -1.69% win: 25% σ: 2.69% n: 4 2022-04-12 → 2026-05-29 (current) | TAK Jul avg: -0.70% median: 0.60% win: 50% σ: 8.21% n: 4 2022-04-12 → 2026-05-29 | TAK Aug avg: 2.89% median: 4.10% win: 75% σ: 6.85% n: 4 2022-04-12 → 2026-05-29 | TAK Sep avg: -3.01% median: -3.42% win: 25% σ: 2.69% n: 4 2022-04-12 → 2026-05-29 | TAK Oct avg: -5.08% median: -5.08% win: 25% σ: 6.26% n: 4 2022-04-12 → 2026-05-29 | TAK Nov avg: 5.12% median: 5.67% win: 75% σ: 5.79% n: 4 2022-04-12 → 2026-05-29 | TAK Dec avg: 3.02% median: 3.38% win: 75% σ: 4.92% n: 4 2022-04-12 → 2026-05-29 |